Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

2.

Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.

Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH.

Eur Heart J. 2016 Jun 21;37(24):1910-9. doi: 10.1093/eurheartj/ehw136. Epub 2016 May 4.

3.

The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Nazir SA, Khan JN, Mahmoud IZ, Greenwood JP, Blackman DJ, Kunadian V, Been M, Abrams KR, Wilcox R, Adgey AA, McCann GP, Gershlick AH.

Trials. 2014 Sep 25;15:371. doi: 10.1186/1745-6215-15-371.

4.

Synchronized defibrillation for ventricular fibrillation.

Darragh KM, Manoharan G, Navarro C, Walsh SJ, Allen JD, Anderson JM, Adgey AJ.

Eur Heart J Acute Cardiovasc Care. 2012 Dec;1(4):285-90. doi: 10.1177/2048872612458498.

5.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
6.

Pre-hospital body surface potential mapping improves early diagnosis of acute coronary artery occlusion in patients with ventricular fibrillation and cardiac arrest.

Daly MJ, Finlay DD, Scott PJ, Nugent CD, Adgey AA, Harbinson MT.

Resuscitation. 2013 Jan;84(1):37-41. doi: 10.1016/j.resuscitation.2012.09.008. Epub 2012 Sep 14.

PMID:
22986067
7.

A low tilt waveform in the transthoracic defibrillation of ventricular arrhythmias during cardiac arrest.

Darragh KM, Manoharan G, Di Maio R, Stevenson M, Bennett JR, Walsh SJ, Allen JD, Anderson JM, Adgey AA.

Resuscitation. 2012 Dec;83(12):1438-43. doi: 10.1016/j.resuscitation.2012.04.018. Epub 2012 May 9.

PMID:
22579679
8.

An innovative piezoelectric-based method for measuring pulse wave velocity in patients with hypertension.

Murphy JC, Morrison K, McLaughlin J, Manoharan G, Adgey AJ.

J Clin Hypertens (Greenwich). 2011 Jul;13(7):497-505. doi: 10.1111/j.1751-7176.2011.00433.x. Epub 2011 Mar 4.

9.

Optimization of the precordial leads of the 12-lead electrocardiogram may improve detection of ST-segment elevation myocardial infarction.

Scott PJ, Navarro C, Stevenson M, Murphy JC, Bennett JR, Owens C, Hamilton A, Manoharan G, Adgey AA.

J Electrocardiol. 2011 Jul-Aug;44(4):425-31. doi: 10.1016/j.jelectrocard.2011.03.010.

PMID:
21704220
10.

Eplerenone in patients with systolic heart failure and mild symptoms.

Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group.

N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.

11.

On the blindside of the ECG lies critical coronary disease.

Daly MJ, Spence MS, Adgey AA.

QJM. 2011 Apr;104(4):365-6. doi: 10.1093/qjmed/hcq097. Epub 2010 Jun 15. No abstract available.

PMID:
20551142
12.

Assessment of the impedance cardiogram recorded by an automated external defibrillator during clinical cardiac arrest.

Cromie NA, Allen JD, Navarro C, Turner C, Anderson JM, Adgey AA.

Crit Care Med. 2010 Feb;38(2):510-7. doi: 10.1097/CCM.0b013e3181c02ca1.

PMID:
19864942
13.

Changes in the frequency spectrum, the P-P interval, and the bispectral index during ventricular fibrillation are physiologic indicators of ventricular fibrillation duration.

Di Maio R, Allen JD, Navarro C, Darragh K, Anderson JM, Adgey AA.

J Electrocardiol. 2009 Nov-Dec;42(6):527-33. doi: 10.1016/j.jelectrocard.2009.06.010. Epub 2009 Jul 23.

PMID:
19631334
14.

ST elevation on the exercise ECG in patients presenting with chest pain and no prior history of myocardial infarction.

Murphy JC, Scott PJ, Shannon HJ, Glover B, Dougan J, Walsh SJ, Adgey AA.

Heart. 2009 Nov;95(21):1792-7. doi: 10.1136/hrt.2008.163691. Epub 2009 Jun 30.

PMID:
19570758
15.

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Brugts JJ, de Maat MP, Boersma E, Witteman JC, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AH, Simoons ML; EUROPA-PERGENE investigators.

Cardiovasc Drugs Ther. 2009 Apr;23(2):171-81. doi: 10.1007/s10557-008-6156-1. Epub 2008 Dec 10.

PMID:
19082699
16.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.

Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P.

Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum in: Lancet. 2008 Oct 18;372(9647):1384.

PMID:
18757085
17.

The impedance cardiogram recorded through two electrocardiogram/defibrillator pads as a determinant of cardiac arrest during experimental studies.

Cromie NA, Allen JD, Turner C, Anderson JM, Adgey AA.

Crit Care Med. 2008 May;36(5):1578-84. doi: 10.1097/CCM.0b013e318170a03b.

PMID:
18434896
18.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

19.

Acute reperfusion strategies for ST-segment elevation myocardial infarction.

Glover BM, Adgey AA.

Eur Heart J. 2008 Mar;29(5):571-2. doi: 10.1093/eurheartj/ehm277. No abstract available.

PMID:
18310670
20.

The Northern Ireland Public Access Defibrillation (NIPAD) study: effectiveness in urban and rural populations.

Moore MJ, Hamilton AJ, Cairns KJ, Marshall A, Glover BM, McCann CJ, Jordan J, Kee F, Adgey AA.

Heart. 2008 Dec;94(12):1614-9. doi: 10.1136/hrt.2007.130534. Epub 2008 Jan 29.

PMID:
18230637
21.

Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial.

Glover BM, Walsh SJ, McCann CJ, Moore MJ, Manoharan G, Dalzell GW, McAllister A, McClements B, McEneaney DJ, Trouton TG, Mathew TP, Adgey AA.

Heart. 2008 Jul;94(7):884-7. Epub 2007 Jun 25.

PMID:
17591649
22.

Preference for pharmacological management of patients with essential hypertension among senior physicians within Northern Ireland.

Murphy JC, Darragh K, Hamilton A, Manoharan G, Adgey AA.

J Hum Hypertens. 2007 Dec;21(12):969-72. Epub 2007 Jun 14. No abstract available.

PMID:
17568752
23.

The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrest.

Cairns KJ, Hamilton AJ, Marshall AH, Moore MJ, Adgey AA, Kee F.

Heart. 2008 Mar;94(3):349-53. Epub 2007 May 31.

PMID:
17540690
24.

Giant true saphenous vein graft aneurysm causing cardiac compression: a rare cause of atrial flutter.

Krishnasamy P, Gillespie JS, McGlinchey PG, Khan MM, Adgey AA.

Int J Cardiol. 2007 Oct 18;121(3):317-9. Epub 2006 Dec 21.

PMID:
17187882
25.
26.

The role of biphasic shocks for transthoracic cardioversion of atrial fibrillation.

Walsh SJ, Glover BM, Adgey AA.

Indian Pacing Electrophysiol J. 2005 Oct 1;5(4):289-95.

27.
28.

Pre-hospital diagnosis of myocardial infarction: an opportunity to improve outcomes?

Walsh SJ, Owens CG, Adgey AA.

Eur Heart J. 2006 Jul;27(13):1515-6. Epub 2006 Jun 7. No abstract available.

PMID:
16760216
29.

Electrocardiographic diagnosis of non-ST-segment elevation acute coronary syndromes: current concepts for the physician.

Owens CG, Adgey AA.

J Electrocardiol. 2006 Jul;39(3):271-4. Epub 2006 May 12.

PMID:
16697403
31.

To examine the effectiveness of a hospital-based nurse-led secondary prevention clinic.

Mainie PM, Moore G, Riddell JW, Adgey AA.

Eur J Cardiovasc Nurs. 2005 Dec;4(4):308-13. Epub 2005 Jul 1.

PMID:
15993647
32.

The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Manoharan G, Maynard SJ, Adgey AA.

Expert Opin Investig Drugs. 1999 May;8(5):555-66.

PMID:
15992115
33.

Demographic and temporal trends in out of hospital sudden cardiac death in Belfast.

Moore MJ, Glover BM, McCann CJ, Cromie NA, Ferguson P, Catney DC, Kee F, Adgey AA.

Heart. 2006 Mar;92(3):311-5. Epub 2005 Jun 6.

34.

Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions.

Walsh SJ, McCarty D, McClelland AJ, Owens CG, Trouton TG, Harbinson MT, O'Mullan S, McAllister A, McClements BM, Stevenson M, Dalzell GW, Adgey AA.

Eur Heart J. 2005 Jul;26(13):1298-302. Epub 2005 Apr 11.

PMID:
15824079
35.

Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction.

McClelland AJ, Owens CG, Walsh SJ, McCarty D, Mathew T, Stevenson M, Gracey H, Khan MM, Adgey AA.

Eur Heart J. 2005 Mar;26(6):544-8. Epub 2005 Feb 15.

PMID:
15713694
36.

Theory and practice of defibrillation: (2) defibrillation for ventricular fibrillation.

Adgey AA, Spence MS, Walsh SJ.

Heart. 2005 Jan;91(1):118-25. Review. No abstract available.

37.

Theory and practice of defibrillation: (1) Atrial fibrillation and DC conversion.

Adgey AA, Walsh SJ.

Heart. 2004 Dec;90(12):1493-8. Review. No abstract available.

38.

Prehospital 80-LAD mapping: does it add significantly to the diagnosis of acute coronary syndromes?

Owens CG, McClelland AJ, Walsh SJ, Smith BA, Tomlin A, Riddell JW, Stevenson M, Adgey AA.

J Electrocardiol. 2004;37 Suppl:223-32.

PMID:
15534846
39.

Managing high-risk patients with acute coronary syndromes: the Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK).

Collinson J, Perez de Arenaza D, Flather MD, Bakhai A, Adgey AA, Fox KA; PRAIS-UK Investigators.

Clin Med (Lond). 2004 Jul-Aug;4(4):369-75.

41.

Efficacy of distinct energy delivery protocols comparing two biphasic defibrillators for cardiac arrest.

Walsh SJ, McClelland AJ, Owens CG, Allen J, Anderson JM, Turner C, Adgey AA.

Am J Cardiol. 2004 Aug 1;94(3):378-80.

PMID:
15276112
42.

Novel uses for recombinant erythropoietin therapy in unlicensed indications.

Macartney CA, Adgey AA, Jones FG, Morris TC, McMullin MF.

Hematol J. 2004;5(2):181-5.

PMID:
15048070
43.

Acute coronary syndromes.

McClelland AJ, Owens CG, Walsh S, Adgey AA.

Clin Med (Lond). 2004 Jan-Feb;4(1):27-31. Review. No abstract available.

44.

Body surface potential mapping improves detection of ST segment alteration during percutaneous coronary intervention.

Maynard SJ, Riddell JW, Menown IB, Allen J, Anderson JM, Khan MM, Adgey AA.

Int J Cardiol. 2004 Feb;93(2-3):203-10.

PMID:
14975548
45.

Current management of unstable angina: lessons from the TACTICS-TIMI 18 trial.

Manoharan G, Adgey AA.

Am J Cardiovasc Drugs. 2002;2(4):237-43. Review.

PMID:
14727969
46.

Transvenous cardioversion--a novel asymmetric rectangular biphasic waveform from a radiofrequency defibrillator compared with conventional waveforms in atrial fibrillation.

Walsh Sj Sj, Manoharan G, Escalona Oj Oj, Evans N, Allen Jd Jd, Anderson JM, Adgey Aa Aa.

J Electrocardiol. 2003;36 Suppl:191-2.

PMID:
14716632
47.

Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).

Armstrong PW, Burton J, Pakola S, Molhoek PG, Betriu A, Tendera M, Bode C, Adgey AA, Bar F, Vahanian A, Van de Werf F; CAPTORS II Investigators.

Am Heart J. 2003 Sep;146(3):484-8.

PMID:
12947367
48.

Body surface mapping improves early diagnosis of acute myocardial infarction in patients with chest pain and left bundle branch block.

Maynard SJ, Menown IB, Manoharan G, Allen J, McC Anderson J, Adgey AA.

Heart. 2003 Sep;89(9):998-1002.

49.

Comparison of the 80-lead body surface map to physician and to 12-lead electrocardiogram in detection of acute myocardial infarction.

McClelland AJ, Owens CG, Menown IB, Lown M, Adgey AA.

Am J Cardiol. 2003 Aug 1;92(3):252-7.

PMID:
12888126
50.

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.

Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, Van de Werf F.

Circulation. 2003 Jul 15;108(2):135-42. Epub 2003 Jul 7.

PMID:
12847070

Supplemental Content

Loading ...
Support Center